Clinical Solutions appoints three C-suite executives to lead product, finance, and talent functions amid strong first-half ...
WCG's Activation Intelligence targets clinical trial rework by catching document conflicts before activation, saving sites ...
ASP-1929 + Pembrolizumab achieved 28.2-month median OS in recurrent/metastatic HNSCC, with 35% alive at four years in Phase ...
A Nature Neuroscience study separates psilocybin's neuroplastic effects from its hallucinogenic ones, and it should reshape ...
MA beneficiaries received kidney transplants at nearly half the rate of traditional Medicare patients post-Cures Act, a ...
Novartis's pelacarsen hit its Lp(a) target in 8,323 patients but missed the cardiovascular endpoint entirely, exposing a $6B ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results